|
|
|
ROCKVILLE, MD April 27, 2001--Celera Genomics (NYSE: CRA), an Applera Corporation business, announced today that it has completed the assembly of the mouse genome. Celera, which began sequencing the mouse in April 2000, has sequenced the 129X1/SvJ, DBA/2J, and A/J strains of mouse. Celera sequenced more than 15.9 billion base pairs of mouse genetic data, and now has approximately 6X-fold coverage of the mouse genome, ensuring greater than 99 percent representation of the mouse genome. The next phase of Celera’s research program will be to annotate the mouse genome to further refine the number and function of mouse genes.
Full press release by Celera Genomics Celera Has Mouse Map And Keeps It - Washington Post (Apr 27, 2001)
Message posted by: Frank S. Zollmann
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|